FDA recall D-1429-2014

Fresenius Kabi USA, LLC · Class II · drug

Product

Fosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL), (PE= phenytoin sodium equivalents) 10 mL Single Use Vial, Rx only, Manufactured for APP Fresenius Kabi USA, LLC Lake Zurich, IL 60047, NDC 63323-403-10

Reason for recall

Presence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials.

Distribution

Nationwide and Puerto Rico

Key facts

Status
Terminated
Initiation date
2014-05-02
Report date
2014-07-16
Termination date
2016-05-24
Voluntary/Mandated
Voluntary: Firm initiated
Location
Melrose Park, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1429-2014